Found 22 matching trials
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma PHASE2 In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Show More Location
Henan cancer hospital
Learn More & Join Trial
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients PHASE2 This study is a prospective, multicenter, open-label, single-arm phase II c...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL NA This study is a prospective, multicenter, open-label, single-arm clinical t...
Show More Location
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University(Huai'an First People's Hospital)
Learn More & Join Trial
Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma PHASE2 This is a prospective, single-center, single-arm, phase II study of Zanubru...
Show More Location
Department of Medical Oncology, Sun Yat-sen University Cancer Center
Learn More & Join Trial
Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma PHASE2 Subjects who met the inclusion/exclusion criteria were included in the expe...
Show More Learn More & Join Trial
Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma PHASE2 This study is planned to prospectively evaluates the efficacy and safety of...
Show More Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin 300020
Learn More & Join Trial
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma PHASE1 The main purpose of this study to find the ideal dose for the combination t...
Show More Location
University of Miami
Learn More & Join Trial
Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma PHASE2 This is a prospective, open-label, single-arm clinical trial evaluating a t...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes PHASE2 This is a prospective, open-label, single-arm, single-center, Phase II clin...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma PHASE2 This is a prospective single arm, multi-center, phase II clinical trial to ...
Show More Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Learn More & Join Trial